Dermaliq Therapeutics Locks In $15M Series A
01/18/22, 4:05 PM
Money raised
$15 million
Round Type
series a
Dermaliq Therapeutics Inc, a new Delaware-based pharmaceutical development company, has raised $15 million in Series A financing.
Company Info
Company
Dermaliq Therapeutics